TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

This study is ongoing, but not recruiting participants.

Study NCT00110877 Information provided by Tibotec Pharmaceuticals, Ireland

First Received: May 13, 2005 Last Updated: September 25, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	February 2012
Estimated Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)